PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 44 filers reported holding PHOENIX BIOTECH ACQUISITION in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 163,538 | $1,679,584 | 0.10% |
| Radcliffe Capital Management, L.P. | 150,000 | $1,540,545 | 0.05% |
| Telemetry Investments, L.L.C. | 125,114 | $5 | 0.01% |
| Q Global Advisors, LLC | 170,785 | $7 | 0.00% |
| Atalaya Capital Management LP | 225,000 | $9,000 | 0.00% |
| DIFESA CAPITAL MANAGEMENT, LP | 62,500 | $2,456 | 0.00% |
| Segantii Capital Management Ltd | 5,000 | $51,000 | 0.00% |
| PERISCOPE CAPITAL INC. | 957,098 | $40,600 | 0.00% |
| MMCAP International Inc. SPC | 375,000 | $16,162 | 0.00% |
| Sage Rock Capital Management LP | 91,999 | $3,965 | 0.00% |